The present study aims at investigating (i) the feasibility in chronic stroke of using a dedicated virtual reality (VR) based system that embeds real-time 3D motion capture and embodied visual feedback to deliver functional exercises designed for training of impaired upper limb motor skills, (ii) whether chronic stroke survivors improve in functional outcomes in the upper limb when exposed to intensive VR-based therapy, and (iii) safety and tolerance to such a technology. The investigators hypothesize that intensive VR-based rehabilitation may lead to high rehabilitation doses and functional improvement in chronic stroke.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Enrollment
10
Patients will receive five weeks of therapy with 2 sessions (minimum) per week lasting for 45-60 minutes each minimum. The training sessions are based on the MindMotion PRO's virtual reality exercises.
Center for Neuroprosthetics-Valais (EPFL) at Clinique Romande de Réadaptation
Sion, Valais, Switzerland
Rehabilitation dose: goal-directed movements (i.e. number of intended movements to achieve a task)
Rehabilitation dose: goal-directed movements (i.e. number of intended movements to achieve a task)
Time frame: 5 weeks
Training intensity: number of goal-directed movements per minute of effective training time.
Training intensity: number of goal-directed movements per minute of effective training time.
Time frame: 5 weeks
Change in Upper limb function assessed with Fugl-Meyer Assessment for Upper Extremity (FMA-UE)
Fugl-Meyer Assessment for Upper Extremity (FMA-UE)
Time frame: At baseline, 5 weeks (post intervention) and 9 weeks (follow-up)
Change in Functional Independence Measure (FIM)
Time frame: At baseline, 5 weeks (post intervention) and 9 weeks (follow-up)
Change in kinematic metrics/goniometry (active range of motion).
Time frame: At baseline, 5 weeks (post intervention) and 9 weeks (follow-up)
Change in Modified Medical Research Council Scale (mMRCS)
Time frame: At baseline, 5 weeks (post intervention) and 9 weeks (follow-up)
Change in Visual Analog Scale (VAS) for Pain
Time frame: At baseline, 5 weeks (post intervention) and 9 weeks (follow-up)
Safety and Acceptance of Technology assessed with a questionnaire
Participants will answer a questionnaire to evaluate following aspects: * Tolerance to VR intervention * Adverse event monitoring * Self-evaluation * Acceptance of technology * Motivation
Time frame: 5 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.